OPTN Gene Amyotrophic lateral sclerosis type 12 Genetic Test
Components
Price: 4400.0 AED
Sample Condition
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
3 to 4 Weeks
Method
NGS Technology
Test Type
Neurological Disorders
Doctor
Neurologist
Test Department
Genetics
Pre Test Information
Clinical History of Patient who is going for OPTN Gene Amyotrophic lateral sclerosis type 12 NGS Genetic DNA Test
A Genetic Counselling session to draw a pedigree chart of family members affected with OPTN Gene Amyotrophic lateral sclerosis type 12
Test Details
The OPTN gene is associated with Amyotrophic lateral sclerosis (ALS) type 12, which is a rare form of ALS. This genetic test is a Next Generation Sequencing (NGS) test that analyzes the OPTN gene to identify any mutations or changes that may be associated with ALS type 12. The test can help diagnose ALS type 12 in individuals who are experiencing symptoms of the disease, or it can be used to determine if individuals with a family history of ALS type 12 are at risk of developing the disease. Early diagnosis can help individuals receive appropriate treatment and support to manage the symptoms of the disease. It is important to note that this test is not a diagnostic tool on its own and should be used in conjunction with other clinical and laboratory tests.
Test Name | OPTN Gene Amyotrophic lateral sclerosis type 12 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for OPTN Gene Amyotrophic lateral sclerosis type 12 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with OPTN Gene Amyotrophic lateral sclerosis type 12 |
Test Details |
The OPTN gene is associated with Amyotrophic lateral sclerosis (ALS) type 12, which is a rare form of ALS. This genetic test is a Next Generation Sequencing (NGS) test that analyzes the OPTN gene to identify any mutations or changes that may be associated with ALS type 12. The test can help diagnose ALS type 12 in individuals who are experiencing symptoms of the disease, or it can be used to determine if individuals with a family history of ALS type 12 are at risk of developing the disease. Early diagnosis can help individuals receive appropriate treatment and support to manage the symptoms of the disease. It is important to note that this test is not a diagnostic tool on its own and should be used in conjunction with other clinical and laboratory tests. |